Donaldson (DCI) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
2 Jun, 2026Executive summary
Achieved record third quarter sales of $995.1 million, up 5.8% year-over-year, with all-time high adjusted operating margin and EPS, driven by strong Mobile Solutions and Life Sciences growth, and disciplined expense management.
Net earnings more than doubled to $118.1 million, with diluted EPS rising to $1.00; adjusted EPS increased 7.1% to $1.06.
Successfully closed the Facet Filtration acquisition for $828.7 million, expanding high-margin recurring revenue and the Industrial Solutions portfolio.
Completed final plant closures under footprint optimization, shifting focus to ramping up productivity at new sites for future efficiencies.
Returned $35 million to shareholders via dividends in Q3; year-to-date dividends paid totaled $104.0 million, with share repurchases of $108.5 million.
Financial highlights
Q3 sales reached $995.1 million, up 5.8% year-over-year, with a 2% benefit from pricing.
Adjusted EPS was $1.06, up 7% year-over-year; operating margin reached 16.6%, up 30 basis points from prior year.
Gross margin was 33.5%, down from 34.2% last year; adjusted gross margin was 34.4%, down 10 basis points year-over-year due to temporary inefficiencies.
Adjusted operating income rose 8% year-over-year; adjusted EBITDA for the quarter was $195.2 million, up from $183.0 million last year.
Adjusted free cash flow for the quarter was $111.6 million, with a cash conversion ratio of 89.0%.
Outlook and guidance
Fiscal 2026 organic sales expected to grow 3%–5%, with pricing and currency each contributing over 1%.
Adjusted EPS guidance set at $3.94–$4.01, up 7–9% year-over-year; Facet acquisition to dilute EPS by ~$0.03.
Adjusted operating margin forecast at 15.8%–16.2%; capital expenditures expected at $60–$75 million; free cash flow conversion 85%–95%.
Life Sciences segment sales outlook raised to 9%–11% for FY26.
Management expects sufficient liquidity to fund operations, debt service, dividends, share repurchases, and acquisitions.
Latest events from Donaldson
- Record results and high-margin growth driven by innovation, pricing, and AI-related demand.DCI
46th Annual William Blair Growth Stock Conference4 Jun 2026 - Facet acquisition and advanced filtration focus position the company for record growth and margins.DCI
Oppenheimer 21st Annual Industrial Growth Virtual Conference4 May 2026 - Record Q2 sales, flat EPS, and $820M Facet acquisition support a strong 2026 outlook.DCI
Q2 20269 Apr 2026 - Record sales and margin growth driven by innovation, global reach, and strategic acquisitions.DCI
47th Annual Raymond James Institutional Investor Conference4 Mar 2026 - Record results and strong outlook driven by aftermarket growth, technology, and disciplined capital strategy.DCI
Morgan Stanley’s 13th Annual Laguna Conference3 Feb 2026 - Life Sciences and innovation drive growth, with record margins and expanding global opportunities.DCI
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Record Q3 sales, margin expansion, and raised EPS guidance highlight robust growth.DCI
Q3 202431 Jan 2026 - Proprietary technology, global expansion, and strategic investments drive growth and resilience.DCI
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Record sales, margin expansion, and robust Aftermarket growth drive FY24 earnings higher.DCI
Q4 202423 Jan 2026